ACP
Acuta Capital Partners Portfolio holdings
AUM
$147M
1-Year Est. Return
491.59%
This Fund
S&P 500
1 Year Est. Return
+491.59%
AUM
$96.8M
AUM Growth
+$25.1M
(+35%)
Holding
36
Top Buys
| 1 | +$3.14M | |
| 2 | +$2.65M | |
| 3 | +$1.8M | |
| 4 |
Krystal Biotech
KRYS
|
+$1.58M |
| 5 |
DRUG
Bright Minds Biosciences
DRUG
|
+$1.41M |
Top Sells
| 1 | +$5.31M | |
| 2 | +$2.7M | |
| 3 | +$2.43M | |
| 4 |
Ascendis Pharma
ASND
|
+$2.38M |
| 5 |
BBOT
BridgeBio Oncology
BBOT
|
+$1.99M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Revolution Medicines
RVMD
$19.7B
| $393K | 0.41% |
8,411
-47,282
|
|
||
27
Unicycive Therapeutics
UNCY
$149M
| $262K | 0.27% |
59,985
-2,914
|
|
||
|
NUVB.WS
28
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $18.4K | 0.02% |
90,832
|
|
||
|
AKRO
29
DELISTED
Akero Therapeutics
AKRO
| – | – |
-19,772
|
|
||
30
Liquidia Corp
LQDA
$2.7B
| – | – |
-75,876
|
|
||
31
Ultragenyx Pharmaceutical
RARE
$2.26B
| – | – |
-23,814
|
|
||
32
Soleno Therapeutics
SLNO
$2.1B
| – | – |
-63,436
|
|
||
33
Trevi Therapeutics
TRVI
$1.53B
| – | – |
-493,735
|
|
||
|
BBOT
34
BridgeBio Oncology
BBOT
$802M
| – | – |
-187,257
|
|
||
|
RAPP
35
Rapport Therapeutics
RAPP
$1.38B
| – | – |
-20,000
|
|
||
|
ARTV
36
Artiva Biotherapeutics
ARTV
$143M
| – | – |
-45,456
|
|